Labcorp (LH)
(Delayed Data from NYSE)
$209.54 USD
+0.33 (0.16%)
Updated Mar 18, 2024 04:00 PM ET
After-Market: $209.54 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
Labcorp (LH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$242.00 | $270.00 | $210.00 | 15.67% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for Labcorp comes to $242.00. The forecasts range from a low of $210.00 to a high of $270.00. The average price target represents an increase of 15.67% from the last closing price of $209.21.
Analyst Price Targets (14)
Broker Rating
Labcorp currently has an average brokerage recommendation (ABR) of 1.78 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 16 brokerage firms. The current ABR compares to an ABR of 1.83 a month ago based on 15 recommendations.
Of the 16 recommendations deriving the current ABR, nine are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 56.25% and 6.25% of all recommendations. A month ago, Strong Buy made up 53.33%, while Buy represented 6.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 9 | 9 | 8 | 9 | 9 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 6 | 6 | 6 | 5 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.78 | 1.78 | 1.83 | 1.70 | 1.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/26/2024 | SVB Securities | Michael Cherny | Not Available | Strong Buy |
2/9/2024 | Evercore Partners | Elizabeth Anderson | Not Available | Hold |
10/26/2023 | William Blair | Andrew F Brackmann | Strong Buy | Strong Buy |
9/15/2023 | Truist Securities | David S Macdonald | Strong Buy | Strong Buy |
9/15/2023 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
8/1/2023 | Argus Research Corp. | Jasper Hellweg | Hold | Hold |
7/31/2023 | Robert W. Baird & Co. | Eric W Coldwell | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.78 |
ABR (Last week) | 1.78 |
# of Recs in ABR | 16 |
Average Target Price | $242.00 |
LT Growth Rate | 9.00% |
Industry | Medical - Dental Supplies |
Industry Rank by ABR | 64 of 252 |
Current Quarter EPS Est: | 3.47 |